Joery De Kock Selected Research

2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acid

1/2022	Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery.
8/2019	Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joery De Kock Research Topics

Disease

6	Inflammation (Inflammations) 07/2021 - 01/2018
4	Fibrosis (Cirrhosis) 01/2022 - 12/2019
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2014
3	Alcoholic Fatty Liver 01/2021 - 01/2018
3	Acute Liver Failure (Fulminant Hepatic Failure) 06/2016 - 09/2015
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
2	Fatty Liver 01/2021 - 03/2016
2	Liver Diseases (Liver Disease) 01/2021 - 01/2018
2	Tyrosinemias (Tyrosinemia) 12/2020 - 10/2019
1	Infections 01/2021
1	Alkaptonuria 10/2019
1	Infertility (Sterility) 10/2017
1	Chemical and Drug Induced Liver Injury 03/2016
1	Hepatitis B 09/2015
1	Seizures (Absence Seizure) 08/2015
1	Epilepsy (Aura) 08/2015
1	Neoplasm Metastasis (Metastasis) 04/2014
1	Liver Neoplasms (Liver Cancer) 08/2012
1	Neoplasms (Cancer) 08/2012

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2022 - 03/2016
3	EnzymesIBA 12/2020 - 01/2015
3	Pharmaceutical PreparationsIBA 12/2019 - 03/2016
2	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 01/2022 - 08/2019
2	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 07/2021 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 12/2020 - 10/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2016 - 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2021
1	CytokinesIBA 07/2021
1	NexusIBA 01/2021
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 12/2020
1	nitisinone (Orfadin)FDA Link 12/2020
1	Amino Acids FDA Link 12/2020
1	Glutathione (Reduced Glutathione)IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Biological ProductsIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2019
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Bosentan (Tracleer)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	LigandsIBA 08/2015
1	Pilocarpine (Ocusert)FDA LinkGeneric 08/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2015
1	BIBP 3226IBA 08/2015
1	neuropeptide FF receptorIBA 08/2015
1	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 08/2015
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2015
1	Keratin-19 (Keratin 19)IBA 04/2014
1	Keratins (Keratin)IBA 04/2014
1	MicroRNAs (MicroRNA)IBA 04/2014
1	ConnexinsIBA 08/2012

Therapy/Procedure

1	Therapeutics 01/2022
1	Bariatric Surgery 01/2022